The FDA approved intravenous tissue plasminogen activator (tPA) for the treatment of patients with acute ischemic stroke more than 15 years ago. Dr. Mark Alberts writes in the current Journal of the American Medical Association (JAMA) that even though tPA is the only...
The Real Stroke Risk is Not Treating Them
read more